SCHEMBL6388495

SCHEMBL6388495

CC(=O)NC1CC(c2cc(NC(=O)C(C)(C)Oc3ccc(Cl)cc3)[nH]n2)C1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP2D6 P10635 1/20 0.47
ALDH1A1 P00352 1/20 0.47
ADORA3 P0DMS8 1/20 0.46
ADORA2A P29274 1/20 0.46
HSD11B1 P28845 12/20 0.45
HSD11B2 P80365 6/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
PPARA Q07869 1/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6388500 1.00 CYP1A2 (0.47) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL3564741 0.86 CYP1A2 (0.51) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL6386704 0.82 HSD11B1 (0.52) CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6
SCHEMBL6386700 0.80 HSD11B1 (0.49) ALDH1A1ADORA3ADORA2AHSD11B1HSD11B2
SCHEMBL6385638 0.78 ATM (0.39) ALDH1A1MEN1KMT2A
SCHEMBL6385633 0.78 ATM (0.39) ALDH1A1MEN1KMT2A
SCHEMBL6385106 0.73 ATM (0.36) ALDH1A1MEN1KMT2A
SCHEMBL6385114 0.73 ATM (0.36) ALDH1A1MEN1KMT2A
SCHEMBL6385230 0.73 MEN1 (0.54) CYP1A2CYP2C9CYP2C19CYP2D6ALDH1A1
SCHEMBL6385235 0.73 MEN1 (0.54) CYP1A2CYP2C9CYP2C19CYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209297-A1 Pyrazole derivatives PFIZER INC 2005-09-22 US claimed
US-20050209297-A1 Pyrazole derivatives PFIZER INC 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209297-A1 Pyrazole derivatives CDK1, CDK3, CDK5 CYP1A2 2580/4885CYP3A4 1927/4885CYP2C9 3051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.